Related Experiment Video
Updated: May 23, 2026

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents
Published on: September 21, 2021
Risk Factors for the Development of Prosthetic Valve Thrombosis After Systemic Atrioventricular Valve Replacement in
Yuya Yamada1, Kenichiro Yamamura2, Ayako Kuraoka1
1Department of Cardiology, Fukuoka Children's Hospital, Fukuoka, Japan.
Abstract:
Risk factors for developing prosthetic valve thrombosis (PVT) after systemic atrioventricular valve replacement in patients with functional single ventricles remain poorly understood. Medical records of 39 operations in 28 patients with functional single ventricles who underwent systemic atrioventricular valve replacement between 1998 and 2021 were retrospectively reviewed. Clinical variables were compared between patients with and without PVT. Median age at operation was 20 (IQR: 10-57) months; body weight was 7.8 (4.9-11.4) kg. Valve size was 21 (19-22) mm, and ratio of valve size (mm) to weight (kg) was 2.4 (1.8-3.6). Valve replacement was performed before bidirectional Glenn procedure (BDG) in 8 cases, with BDG in 7 cases, between BDG and total cavopulmonary connection (TCPC) in 13 cases, with TCPC in 4 cases, and after TCPC in 7 cases. PVT occurred after 12 of 39 operations (31%). Significant differences existed in median age at operation (12 vs. 26 months, p = 0.003), median weight at operation (4.9 vs. 10.2 kg, p = 0.001), and median valve size/weight ratio (3.6 vs. 2.1, p = 0.002) between operations with and without PVT. PVT incidence was higher before TCPC completion: before BDG (4/8 operations, 50%), BDG (3/7, 43%), and between BDG and TCPC (5/13, 38%), compared to TCPC (0/4, 0%) and after TCPC (0/7, 0%) (p < 0.001). Patients who developed PVT were younger and underweight; in these patients, the use of a relatively oversized prosthesis is clinically inevitable. Close monitoring for PVT is warranted, especially before TCPC completion.
More Related Videos
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Stenosis I: Introduction
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management

